LEELA GUPTA: Open Payments
NPI 1497417612 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$470 in 15 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $312 · 2025 $470
Food & beverage: $470
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 3 | $112 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $100 |
| AstraZeneca Pharmaceuticals LP | 4 | $82 |
| Merck Sharp & Dohme LLC | 2 | $52 |
| Kestra Medical Technology Services, Inc. | 1 | $47 |
| Impulse Dynamics (USA) Inc. | 1 | $38 |
| Philips North America LLC | 1 | $38 |
Products named: JARDIANCE, ONPATTRO, FARXIGA, VERQUVO, Assure WCD, Optimizer, MCOT, AMVUTTRA.
Industry payments across NY — which companies pay providers there.
